Leonardo Roever: CHR as a Composite Biomarker for Stroke Risk Stratification
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Wei Huang et al, published in Lipids in Health and Disease:
”Association of C-reactive protein/HDL cholesterol ratio with stroke in Chinese adults with different glycemic levels
Stroke is one of the major public health problems in China, highlighting the need for accessible biomarkers to aid in risk stratification.
The C-reactive protein/HDL cholesterol (CHR) ratio, which integrates inflammatory and lipid pathways, has emerged as a new composite biomarker.
Higher CHR levels were associated with an increased risk of stroke in Chinese adults, with heterogeneity between different glycemic levels, showing stronger and nonlinear (J-shaped) associations in individuals with normal blood glucose than in individuals with diabetes.
CHR has demonstrated limited discriminatory ability for stroke, suggesting that its usefulness may lie in risk stratification rather than isolated prediction.
Follow me for more content on evidence, management, and innovation in health
Enroll now in the courses offered by the Brazilian Evidence-Based Health Network and take your research and scientific knowledge to the next level.”
Title: Association of C-reactive protein/high-density lipoprotein cholesterol ratio with stroke in Chinese adults across different glycemic status
Authors: Wei Huang, Jun Gu, Xueli Sun, Zhimei Shen, Qin Yin, Xu Wang
Read the Full Article on BMC/Lipids in Health and Disease
Stay updated on all scientific advances with Hemostasis Today.
-
May 20, 2026, 10:40Sameh Sayfo: Join Two Live Webinars on the New AHA Guidelines
-
May 20, 2026, 10:24How to Recognize Stroke Symptoms Instantly – Duke Health
-
May 20, 2026, 08:27Ahmed Koriesh: Persistent Delays, Higher Mortality, and Opportunities for Improvement for In-Hospital Stroke
-
May 20, 2026, 08:18ASH Launches Comprehensive Clinical Trial Learning Tool
-
May 20, 2026, 08:06Syed Mushahid Hussain: One of the Biggest Mistakes in CBC Interpretation is Analyzing Values in Isolation
-
May 20, 2026, 08:03Ann Marie O’Neill: Help Us Improve Information for DOAC Medicines
-
May 20, 2026, 08:03Tareq Abadl: Exploring the Clinical Power of Serum Protein Electrophoresis
-
May 20, 2026, 07:51Haroun Gajraj: Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
-
May 20, 2026, 07:50Karen Schreiber: The BBQ Trial and the Challenge of Conducting Pregnancy RCTs